Michigan State University, Breslin Cancer Center — Lansing, Michigan

Michigan State University, Breslin Cancer Center is a clinical research site located in Lansing, Michigan, United States 48910.

Crixeo Health Trust Score: 66/100 (FAIR). This profile has not yet been claimed by the site owner.

Michigan State University, Breslin Cancer Center has participated in 4 clinical trials with 1 currently active.

Therapeutic areas: Clear Cell Renal Carcinoma, Breast Cancer, Myelodysplastic Syndromes.

Sponsors: Arkadiusz Z. Dudek, MD, Nancy Chan, MD, Helsinn Healthcare SA.

Sponsor Feasibility Report

Trust Score: 66/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Michigan State University, Breslin Cancer Center?

Michigan State University, Breslin Cancer Center has a Crixeo Trust Score of 66/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Michigan State University, Breslin Cancer Center conducted?

Michigan State University, Breslin Cancer Center has 4 clinical trials on record, with 1 currently active. Their work covers Clear Cell Renal Carcinoma, Breast Cancer, Myelodysplastic Syndromes.

Is Michigan State University, Breslin Cancer Center accredited by Crixeo Health?

Michigan State University, Breslin Cancer Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Michigan State University, Breslin Cancer Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.